Opioid Dependence Clinical Trial
Official title:
Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments
This study will compare the effects of brief strengths-based case management (SBCM) to the effects of screening, assessment and referral alone (SAR) in opioid-dependent patients. Participants meeting DSM-IV criteria for opioid dependence will be randomly assigned (150 per group) to receive 1) up to 6 sessions of SBCM; or 2) SAR. Follow-up assessments will be completed at 3 and 6 months, by staff who are blinded to treatment condition.
As addiction treatment becomes increasingly integrated into the medical care system, two
models have rightly received a great deal of attention. The first is the use of Screening,
Brief Intervention, and Referral to Treatment (SBIRT) models to identify cases, provide
therapeutic contact, and refer the more severe cases to longer-term care. The second is the
treatment of addictions using medical models of treatment, including those that can be
implemented in primary care settings. Much less attention has been paid to optimizing
strategies for bridging the gap between SBIRT and more intensive/longer-term treatment for
those on the severe end of the spectrum. This factor is of critical importance for opioid
dependent patients, whose needs are not met by brief interventions or brief treatment.
Emergency room interventions for substance use disorders have been largely limited to brief
interventions/SBIRT models, and these have focused primarily on alcohol. Although there is a
substantial literature documenting the value of case management in linking drug users to
treatment, this approach has not been applied to drug users in the emergency department (ED)
setting.
In a sample of opioid dependent patients seen in a medical ED who are not currently engaged
in treatment, this study will compare the effects of brief strengths-based case management
(SBCM) to the effects of screening, assessment and referral alone. Participants meeting
DSM-IV criteria for opioid dependence will be randomly assigned (150 per group) to receive 1)
Screening, Assessment and Referral or 2) up to 6 sessions of SBCM based on the model
previously implemented by Rapp and colleagues in prior studies. Staff who are blinded to
treatment condition will complete follow-up assessments at 3 and 6 months. Aims of the study
are to identify the main effects of SBCM on substance abuse treatment initiation and
engagement, use of opioids and other drugs, and broader measures of health and life
functioning; to examine the interactions between treatment assignment and selected
participant attributes in predicting treatment initiation, engagement, and substance use
outcomes; and to examine effects of treatment involvement on substance use outcomes in the
two treatment groups.
The proposed study will be the first trial using a case management approach to link drug
dependent patients presenting in EDs to longer-term addiction treatment. It will be one of
the first trials focusing specifically on opioid dependent patients in medical EDs. A further
innovative feature is that the case management approach will emphasize linkage to
pharmacotherapy, facilitating linkage to office-based buprenorphine, methadone, or naltrexone
for patients who desire this treatment.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03675386 -
Reducing Opioid Use for Chronic Pain Patients Following Surgery
|
N/A | |
Completed |
NCT02593474 -
Medication-Assisted Treatment for Youth With Substance Use Disorders
|
Phase 1 | |
Completed |
NCT02294253 -
Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone
|
Phase 2/Phase 3 | |
Completed |
NCT02282306 -
Phone Interview to Prevent Recurring Opioid Overdoses
|
N/A | |
Completed |
NCT01592461 -
Starting Treatment With Agonist Replacement Therapies Follow-up Study
|
N/A | |
Terminated |
NCT00768482 -
A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence
|
Phase 3 | |
Completed |
NCT01741350 -
Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users
|
N/A | |
Terminated |
NCT04121546 -
Collaborative Care for Opioid Dependence And Pain Pilot Study
|
N/A | |
Withdrawn |
NCT03368794 -
Naloxone to TReatment Entry in the Emergency Setting
|
N/A | |
Completed |
NCT03447743 -
Re-entry XR-NTX for Rural Individuals With Opioid Use Disorder
|
Early Phase 1 | |
Completed |
NCT04464421 -
SMART Effectiveness Trial
|
N/A | |
Recruiting |
NCT04189523 -
Does Early Administration of Ultrasound Guided Regional Anesthesia for Long Bone Fractures Effect Long Term Patient Opioid Usage
|
N/A | |
Completed |
NCT03305666 -
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
|
Phase 4 | |
Recruiting |
NCT04003948 -
Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification
|
Phase 2 | |
Not yet recruiting |
NCT03813095 -
Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction
|
Phase 2 | |
Terminated |
NCT02935101 -
Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants
|
Phase 2 | |
Completed |
NCT01895270 -
Improving Buprenorphine Detoxification Outcomes With Isradipine
|
Phase 1/Phase 2 | |
Completed |
NCT01717963 -
Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway
|
Phase 3 | |
Completed |
NCT02324725 -
Biomarkers of Injectable Extended Release Naltrexone Treatment
|
Phase 4 | |
Completed |
NCT01425060 -
Improving Effective Contraceptive Use Among Opioid-maintained Women
|
Phase 1 |